MET kinase-IN-2

MET kinase-IN-2 is a potent, selective, orally bioavailable MET kinase inhibitor with an IC50 of 7.4 nM. MET kinase-IN-2 has antitumor activity[1].

Product Specifications

CAS Number

[2101241-90-9]

UNSPSC

12352005

Target

C-Met/HGFR

Type

Reference compound

Related Pathways

Protein Tyrosine Kinase/RTK

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/met-kinase-in-2.html

Purity

98.39

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C1C(C2=CC=CC=C2)=CNC3=C1C(NC4=CC=C(OC5=CC=NC6=CC(OCC(C)(O)C)=CC=C56)C(F)=C4)=NC=C3

Molecular Formula

C33H27FN4O4

Molecular Weight

562.59

References & Citations

[1]Chen T, et al. Discovery of 1,6-naphthyridinone-based MET kinase inhibitor bearing quinoline moiety as promising antitumor drug candidate. Eur J Med Chem. 2020;192:112174.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, protect from light, stored under nitrogen)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

E47R24046 100 µL

ECM1 Rabbit pAb

View Details

039676-HRP 200 µL

PARP1, phosphorylated (T373) (PARP1, ADPRT, PPOL, Poly [ADP-ribose] polymerase 1, ADP-ribosyltransferase diphtheria toxin-like 1, NAD (+) ADP-ribosyltransferase 1, Poly[ADP-ribose] synthase 1) (Azide free) (HRP) discontinued

View Details

sc-351674 250 mg

9-Oxo-1,2,3,9-tetrahydro-pyrrolo[2,1-b]quinazoline-6-carboxylic acid hydrazide

View Details

36-2955-100 100 µg

Anti-ACTH (Adrenocorticotrophic Hormone) (C-Terminus) Monoclonal Antibody (Clone: rCLIP/1418)

View Details

VAng-Cr8355-50gEcoli 50 µg (E. coli)

Recombinant Streptococcus Suis rpsF Protein (aa 1-96)

View Details

PV004407 500 ng

BUB3 Protein Vector (Human) (pPM-C-HA)

View Details